**Question:** Which of the following drugs is used against bacteria Pseudomonas aeruginosa?

**Core Concept:** Pseudomonas aeruginosa is a gram-negative bacterium that can cause infections in various parts of the body, especially in immunocompromised individuals and those with underlying medical conditions. It is often resistant to multiple antibiotics, making treatment challenging.

**Why the Correct Answer is Right:**

Correct Answer: **C. Ceftazidime**

Ceftazidime is a broad-spectrum cephalosporin antibiotic that binds to penicillin-binding proteins, inhibiting bacterial cell wall synthesis and leading to cell lysis. Pseudomonas aeruginosa is susceptible to ceftazidime due to its beta-lactamase enzymes not being able to break down ceftazidime efficiently.

**Why Each Wrong Option is Incorrect:**

A. **Aztreonam (Option A) is a monobactam antibiotic, which is also a beta-lactam antibiotic. However, Pseudomonas aeruginosa possesses beta-lactamase enzymes that can break down aztreonam, rendering it less effective against this bacterium.

B. **Amoxicillin (Option B) is a penicillin antibiotic, similar to ceftazidime, but Pseudomonas aeruginosa can produce beta-lactamase enzymes that degrade amoxicillin, decreasing its effectiveness against this bacterium.

D. **Nitrofurantoin (Option D) is a urinary tract antibiotic used for treating infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa. However, Pseudomonas aeruginosa can develop resistance mechanisms such as mutations in the target proteins or the production of beta-lactamase enzymes, which reduces the effectiveness of nitrofurantoin against this bacterium.

**Clinical Pearl:** Pseudomonas aeruginosa infections can be challenging to treat due to its ability to develop resistance mechanisms. Ceftazidime remains a valuable option for treating Pseudomonas aeruginosa infections, but the use of combination therapy with an antipseudomonal beta-lactamase inhibitor, such as clavulanic acid (e.g., tazobactam), can enhance the effectiveness of beta-lactam antibiotics like ceftazidime against Pseudomonas aeruginosa infections.

**Why the Correct Answer is Right:**

Ceftazidime is a broad-spectrum beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Since Pseudomonas aeruginosa does not produce beta-lactamase enzymes, it is more susceptible to ceftazidime compared to other beta-lactam antibiotics like aztreonam (Option B) and amoxicillin (Option B). However, the use of an antipseudomonal beta-lactamase inhibitor like clavulanic acid (Option C) can significantly enhance the effectiveness of ceftazidime against Pseudomonas aeruginosa infections by inhibiting the activity of beta-lactamase enzymes produced